Saraf and Partners acted for Viatris on the deal, and Willkie Farr & Gallagher acted for Cooper Consumer Health Global healthcare leader Viatris, (formerly known as...
Iquest Enterprises’ Acquisition of Women’s Healthcare and API From Viatris
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...